ABBOTT
ActiveSummary
ABBOTT has been active since 1948 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.10bn and a net result of €369.8m. Equity remains stable across the filed financial years (±0.3% per year). Its solvency ranks better than 93% of 6,152 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Staff
- 71.2 FTE
- Equity
- €2.10bn
- Profit
- €369.8m
- Parent
- ABBOTT LABORATORIES
- Holdings
- 9
- Bradley Jay SlaterDirector
- Maya Abdel Ahad WakimManaging director
Why 91raises riskLiquidity: current ratio 0.19, cash €1.1m, halved1 of the last 3 latelowers riskFounded in 1948Size: turnover €105.6m, 71.2 FTE, total assets €2.34bnShow the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 93% on solvency, 71% on liquidity, 31% on profitability and 50% on growth.
The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 19 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · full…
- Resignations & appointmentsPower of attorney
- Resignation: Hendrikus Lueb (director)Appointment: Maya Abdel Ahad Wakim…
Financials · financial year 2025, full format
2021 to 2025, 5 financial years 2019 to 2025, 6 financial years
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 94% above 2024 and is the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
| Line | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|
| Operating income70/76A | €81.2m | €95.8m | €93.1m | €95.6m | €100.0m | €107.3m | ▲ 7.3% |
| Turnover70 | €78.8m | €94.1m | €91.4m | €93.6m | €98.3m | €105.6m | ▲ 7.4% |
| Other operating income74 | €2.3m | €1.7m | €1.7m | €2.0m | €1.7m | €1.7m | ▼ 0.3% |
| Operating charges60/66A | €79.4m | €94.1m | €92.8m | €93.5m | €97.8m | €103.0m | ▲ 5.3% |
| Goods for resale, raw materials and consumables60 | €57.2m | €72.1m | €69.0m | €65.6m | €71.8m | €76.5m | ▲ 6.6% |
| Purchases600/8 | - | - | - | €64.7m | €70.9m | €75.4m | ▲ 6.4% |
| Change in stocks: decrease (increase)609 | -€0.1m | €0.7m | €0.6m | €1.0m | €0.9m | €1.1m | ▲ 24.2% |
| Services and other goods61 | €6.6m | €7.0m | €7.1m | €8.3m | €9.9m | €9.9m | ▼ 0.1% |
| Remuneration, social security and pensions62 | €13.1m | €11.7m | €13.5m | €13.5m | €13.0m | €13.7m | ▲ 5.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1.9m | €2.1m | €2.1m | €2.5m | €2.7m | €2.5m | ▼ 7.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €0.07m | €0.4m | €0.09m | €0.4m | €0.2m | -€0.2m | - |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €0.04m | €0.1m | -€0.08m | €2.2m | -€0.01m | €0.2m | - |
| Other operating charges640/8 | €0.2m | €0.8m | €1.0m | €0.9m | €0.2m | €0.3m | ▲ 36.0% |
| Non-recurring operating charges66A | €0.2m | €0.02m | €0.02m | €0.002m | €0.003m | €0.06m | ▲ 21× |
| Operating profit (loss)9901 | €1.7m | €1.7m | €0.3m | €2.1m | €2.2m | €4.3m | ▲ 94.0% |
| Financial income75/76B | - | - | - | €0.05m | €0.1m | €369.5m | ▲ 2,798× |
| Recurring financial income75 | €500.4m | €65.1m | €219.8m | €0.05m | €0.1m | €369.5m | ▲ 2,798× |
| Income from financial fixed assets750 | €500.0m | €65.0m | €219.8m | - | - | €369.5m | - |
| Income from current assets751 | €0.4m | - | - | - | - | - | - |
| Other financial income752/9 | €0.04m | €0.07m | - | €0.05m | €0.1m | - | - |
| Non-recurring financial income76B | €0.01m | €0.04m | - | - | - | €0.006m | - |
| Financial charges65/66B | €5.2m | €0.4m | €1.7m | €7.0m | €7.6m | €4.8m | ▼ 37.1% |
| Recurring financial charges65 | €1.1m | €0.4m | €1.7m | €7.0m | €7.6m | €4.8m | ▼ 37.1% |
| Debt charges650 | €0.7m | €0.09m | €0.6m | €6.8m | €7.6m | €4.7m | ▼ 37.7% |
| Other financial charges652/9 | €0.3m | €0.3m | €1.2m | €0.1m | €0.03m | €0.06m | ▲ 102% |
| Non-recurring financial charges66B | €4.2m | - | - | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €496.9m | €66.4m | €218.4m | -€4.8m | -€5.3m | €369.0m | - |
| Income taxes67/77 | €0.4m | €0.2m | €0.6m | -€0.5m | €0.1m | -€0.8m | - |
| Taxes670/3 | €0.4m | €0.2m | €0.6m | - | €0.1m | - | - |
| Tax adjustments and reversals of tax provisions77 | - | - | - | €0.5m | - | €0.8m | - |
| Profit (loss) for the period9904 | €496.5m | €66.2m | €217.8m | -€4.3m | -€5.4m | €369.8m | - |
| Profit (loss) for the period to be appropriated9905 | €496.5m | €66.2m | €217.8m | -€4.3m | -€5.4m | €369.8m | - |
| Line | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total assets20/58 | €3,379.0m | €2,326.6m | €2,328.8m | €2,335.8m | €2,339.1m | €2,338.1m | = |
| Fixed assets21/28 | €2,291.6m | €2,295.9m | €2,297.2m | €2,296.8m | €2,297.4m | €2,295.1m | ▼ 0.1% |
| Intangible fixed assets21 | - | €0.002m | €0.002m | €0.2m | €0.2m | €0.2m | = |
| Tangible fixed assets22/27 | €12.4m | €13.6m | €14.9m | €15.3m | €16.0m | €13.7m | ▼ 14.4% |
| Furniture and vehicles24 | €0.1m | €0.1m | €0.2m | €0.3m | €0.3m | €0.3m | ▲ 12.3% |
| Other tangible fixed assets26 | €10.8m | €13.5m | €14.7m | €15.0m | €15.7m | €13.4m | ▼ 14.8% |
| Assets under construction and advance payments27 | €1.4m | - | - | - | - | €0.003m | - |
| Financial fixed assets28 | €2,279.3m | €2,282.3m | €2,282.3m | €2,281.3m | €2,281.2m | €2,281.2m | = |
| Affiliated companies280/1 | €2,278.6m | €2,281.4m | €2,281.4m | €2,280.1m | €2,280.1m | €2,280.1m | = |
| Participating interests280 | €2,278.6m | €2,281.4m | €2,281.4m | €2,280.1m | €2,280.1m | €2,280.1m | = |
| Other financial fixed assets284/8 | €0.7m | €0.9m | €1.0m | €1.2m | €1.1m | €1.1m | ▼ 0.6% |
| Amounts receivable and cash guarantees285/8 | €0.7m | €0.9m | €1.0m | €1.2m | €1.1m | €1.1m | ▼ 0.6% |
| Current assets29/58 | €1,087.3m | €30.7m | €31.6m | €39.0m | €41.7m | €43.0m | ▲ 3.1% |
| Stocks and contracts in progress3 | €1.2m | €2.4m | €1.6m | €2.7m | €1.1m | €0.7m | ▼ 43.0% |
| Stocks30/36 | €1.2m | €2.4m | €1.6m | €2.7m | €1.1m | €0.7m | ▼ 43.0% |
| Goods purchased for resale34 | €1.2m | €2.4m | €1.6m | €2.7m | €1.1m | €0.7m | ▼ 43.0% |
| Amounts receivable within one year40/41 | €1,083.5m | €25.5m | €27.7m | €31.7m | €37.8m | €41.1m | ▲ 8.7% |
| Trade receivables40 | €21.1m | €23.9m | €27.5m | €31.5m | €37.6m | €41.0m | ▲ 9.1% |
| Other amounts receivable41 | €1,062.3m | €1.6m | €0.3m | €0.2m | €0.2m | €0.08m | ▼ 60.7% |
| Cash at bank and in hand54/58 | €2.4m | €2.8m | €2.2m | €4.5m | €2.6m | €1.1m | ▼ 58.6% |
| Deferred charges and accrued income490/1 | €0.2m | - | - | €0.1m | €0.2m | €0.2m | ▲ 11.6% |
| Equity and liabilities | |||||||
| Total equity and liabilities10/49 | €3,379.0m | €2,326.6m | €2,328.8m | €2,335.8m | €2,339.1m | €2,338.1m | = |
| Equity10/15 | €2,140.3m | €2,142.5m | €2,114.2m | €2,109.9m | €2,108.1m | €2,104.8m | ▼ 0.2% |
| Contributions10/11 | €3,325.7m | €3,260.7m | €3,014.6m | €3,014.6m | €3,014.6m | €2,645.2m | ▼ 12.3% |
| Capital10 | €3,325.7m | €3,260.7m | €3,014.6m | €3,014.6m | €3,014.6m | €2,645.2m | ▼ 12.3% |
| Issued capital100 | €3,325.7m | €3,260.7m | €3,014.6m | €3,014.6m | €3,014.6m | €2,645.2m | ▼ 12.3% |
| Reserves13 | €32.9m | €36.2m | €47.1m | €47.1m | €47.1m | €47.1m | = |
| Non-distributable reserves130/1 | - | €36.2m | €47.1m | €47.1m | €47.1m | €47.1m | = |
| Legal reserve130 | €32.9m | €36.2m | €47.1m | €47.1m | €47.1m | €47.1m | = |
| Reserves not available under the articles1311 | €0.001m | - | - | - | - | - | - |
| Other1319 | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Profit (loss) carried forward14 | -€1,218.3m | -€1,154.5m | -€947.6m | -€951.9m | -€953.7m | -€587.5m | ▲ 38.4% |
| Provisions and deferred taxes16 | €0.4m | €0.5m | €0.4m | €0.8m | €1.0m | €1.2m | ▲ 21.9% |
| Provisions for liabilities and charges160/5 | €0.4m | €0.5m | €0.4m | €0.8m | €1.0m | €1.2m | ▲ 21.9% |
| Pensions and similar obligations160 | €0.08m | - | - | - | - | - | - |
| Other liabilities and charges164/5 | €0.3m | €0.5m | €0.4m | €0.8m | €1.0m | €1.2m | ▲ 21.9% |
| Amounts payable17/49 | €1,238.2m | €183.7m | €214.3m | €225.2m | €230.1m | €232.1m | ▲ 0.9% |
| Amounts payable within one year42/48 | €1,237.5m | €183.0m | €213.3m | €224.6m | €229.1m | €230.9m | ▲ 0.8% |
| Trade debts44 | €10.7m | €9.0m | €9.8m | €15.1m | €15.5m | €13.1m | ▼ 15.6% |
| Suppliers440/4 | €10.7m | €9.0m | €9.8m | €15.1m | €15.5m | €13.1m | ▼ 15.6% |
| Taxes, remuneration and social security45 | €5.3m | €5.2m | €6.6m | €4.5m | €3.9m | €5.2m | ▲ 34.3% |
| Taxes450/3 | €1.6m | €1.5m | €2.8m | €0.8m | €0.3m | €1.2m | ▲ 284% |
| Remuneration and social security454/9 | €3.7m | €3.6m | €3.8m | €3.8m | €3.6m | €4.0m | ▲ 13.0% |
| Other amounts payable47/48 | €1,221.6m | €168.8m | €196.9m | €205.0m | €209.7m | €212.6m | ▲ 1.4% |
| Accrued charges and deferred income492/3 | €0.7m | €0.7m | €0.9m | €0.5m | €1.0m | €1.2m | ▲ 22.3% |
| Line | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €496.5m | €66.2m | €217.8m | -€4.3m | -€5.4m | €369.8m | - |
| + Depreciation and write-downs630 | €1.9m | €2.1m | €2.1m | €2.5m | €2.7m | €2.5m | ▼ 7.6% |
| Operating cash flow (approximation) | €498.4m | €68.3m | €219.9m | -€1.8m | -€2.7m | €372.3m | - |
| Investment in fixed assets (approximation) | - | - | -€3.4m | -€2.1m | -€3.4m | -€0.2m | ▲ 93.8% |
| Change in cash | - | - | -€0.6m | €2.2m | -€1.9m | -€1.5m | ▲ 19.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 49 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | full format | 03-07-2026 | 2026-00244956 |
| 31-12-2024 | full format | 12-12-2025 | 2025-00581178 |
| 31-12-2023 | full format | 10-07-2024 | 2024-00245182 |
| 31-12-2022 | full format | 05-07-2023 | 2023-00213064 |
| 31-12-2021 | full format | 23-08-2022 | 2022-20309821 |
| 31-12-2020 | full format | 27-07-2021 | 2021-42800478 |
| 31-12-2019 | full format | 23-09-2020 | 2020-55500164 |
| 31-12-2018 | full format | 30-12-2019 | 2019-77900550 |
| 31-12-2017 | full format | 27-09-2018 | 2018-66500521 |
| 31-12-2016 | full format | 29-06-2017 | 2017-25400270 |
Similar companies · same sector, comparable size
Public contracts
Show 2 more contracts
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. Values as the buyer published them; for a framework agreement, a ceiling.
Directors
Board 2
Day-to-day management 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Bradley Jay Slater |
|
| Maya Abdel Ahad Wakim |
|
| Ernst & Young Réviseurs d'Entreprises SRL |
|
| Hendrikus Lueb |
|
| Benjamin Edward Oosterbaan |
|
Owners and capital
Owners
3 ownersChain of control
- ABBOTT LABORATORIESUS
- ABBOTT
Highest known parent: ABBOTT LABORATORIES (United States). The sources do not say who stands above it.
Owners 3
- St Jude Medical International HoldingLUparentSourceown accounts 2025100%
- ABBOTT LABORATORIESUSparentSourceLEI registerconsolidated
- Abbott Holding Gibraltar LimitedMTSourceown accounts 20250%
According to the 2025 annual accounts of ABBOTT and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 07-10-2025 Capital reduction of €369,454,545 · to €2,645,169,512.30 · repaid to the shareholders
- 31-10-2022 Capital reduction of €246,108,367 · to €3,014,624,057.30 · repaid to the shareholders
Group and network
Holdings and subsidiaries
9 holdingsHoldings 9
Source for every holding own accounts 2025
- ABBOTT ASIA INVESTMENTS LTDGBsubsidiaryEquity GBP 1.69bnResult GBP 222.5m100%
- ABBOTT LABORATORIOS LDAPTsubsidiaryEquity €39.3mResult €2.6m100%
-
100%
- Abbott Medical HellasGRsubsidiaryEquity €18.4mResult €669,538100%
- Abbott Medical Italia SPAITsubsidiaryEquity €109.5mResult €6.8m100%
- Abbott Norge ASNOsubsidiaryEquity NOK 132.7mResult NOK 20.9m100%
- Abbott Rapid DiagnosticssubsidiaryEquity €6.8mResult €317,389100%
- ABBOTT srlITsubsidiaryEquity €218.4mResult €16.8m100%
- KNOLL UK INVESTMENTS UNLIMITEDGBsubsidiaryEquity USD 221.1mResult USD 8.8m100%
Stated earlier (1)
An older source named these holdings; newer accounts no longer list them.
-
100%
According to the 2025 annual accounts of ABBOTT and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
2 current directorsThe board mandates are listed below; here you explore them as a network.
Board mandates elsewhere
1 board mandateHistory
Acts, filings and financial milestones
23-02
Gazette deed
Resignations & appointmentsPower of attorney3 facts ▸
- Board meeting, 12-01-2026
- Power of attorney, Freek Heuyerjans
- Power of attorney, Frank Heyvaert
20-01
Gazette deed
Resignation: Hendrikus Lueb (director)Appointment: Maya Abdel Ahad Wakim (director) · Power of attorney7 facts ▸
- General meeting, 17-12-2025
- Director resignation, Hendrikus Lueb (director)
- Director appointment, Maya Abdel Ahad Wakim (director)
- Board meeting, 18-12-2025
- Director resignation, Hendrikus Lueb (managing director)
- Power of attorney, Hendrikus Lueb
- Director appointment, Maya Abdel Ahad Wakim (managing director)
07-10
Gazette deed
Capital & shares · Amendment of the articlesCapital decrease · Capital4 facts ▸
- General meeting, 03-10-2025
- Capital decrease, €369,454,545
- Capital, €2,645,169,512.30
- Amendment of the articles, 5
30-10
Gazette deed
Resignations & appointmentsPower of attorney4 facts ▸
- Board meeting, 09-09-2024
- Power of attorney, Martine Aerts
- Power of attorney, Oliver Leonhardt
- Other provision, “Nom et qualité du notaire instrumentant ou de la personne ou des personnes ayant pouvoir de représenter la personne morale à l'égard des tiers, recto verso” (deed in French)
07-10
Gazette deed
Permanent representatives: Piet Hemschoote and Filip Simpelaere3 facts ▸
- General meeting, 09-09-2024
- Permanent representative, Piet Hemschoote
- Permanent representative, Filip Simpelaere
27-11
Gazette deed
Resignations & appointmentsPower of attorney2 facts ▸
- Board meeting, 05-10-2023
- Power of attorney, Régine Tobback
04-10
Gazette deed
Reappointment: Ernst & Young Réviseurs d'Entreprises SRL (statutory auditor)2 facts ▸
- General meeting, 30-06-2023
- Auditor reappointment, Ernst & Young Réviseurs d'Entreprises SRL (statutory auditor)
Show earlier events
14-07
Gazette deed
Resignations & appointmentsPower of attorney · Director in office3 facts ▸
- Board meeting, 21-06-2023
- Power of attorney, Kris Vanderhoydonck (business unit manager adc belgium)
- Director in office, Hendrikus A.M. Lueb (managing director)
24-05
Gazette deed
Resignations & appointmentsPower of attorney3 facts ▸
- Board meeting, 10-04-2023
- Power of attorney, Maxime Labbé
- Power of attorney, Freek Heuyerjans
14-11
Gazette deed
Resignation: Benjamin Edward Oosterbaan (director)Appointment: Bradley Jay Slater (director)3 facts ▸
- General meeting, 21-10-2022
- Director resignation, Benjamin Edward Oosterbaan (director)
- Director appointment, Bradley Jay Slater (director)
31-10
Gazette deed
Capital & sharesCapital decrease · Amendment of the articles3 facts ▸
- General meeting, 27-10-2022
- Capital decrease, €246,108,367
- Amendment of the articles, 5
About the unread acts
Of the 67 Belgian Official Gazette deeds we know for this company, 11 have been read. The other 56 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Legal Entity Identifier
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 25112N0041/00B000 | Wallonia | 1.5 ha | 1 · 832 m² | 21.3 m · 6 |